English
This article is from Urologic Oncology , volume 32 . Abstract Purpose: To assess the performance of multiparametric magnetic resonance imaging (mp-MRI) in patients with previous negative transrectal ultrasound (TRUS) guided prostate biopsy. Materials and methods: Fifty-four patients with at least 1 previous negative TRUS prostate biopsy underwent mp-MRI in the form of T2-weighted, diffusion-weighted, and dynamic contrast-enhanced imaging. This was followed by transperineal template systematic prostate biopsies. Analysis was done based on 2 sectors per prostate, right and left (108 sectors out of 54 prostates). mp-MRI was scored using an ordinal scale 1 to 5 based on the suspicion of the presence of clinically significant disease. We used 6 different definitions for clinically significant disease and tested the performance of mp-MRI at each single definition. Results: Median age was 64 (range, 39–75), median PSA level was 10 (range, 2–23), and median number of biopsies was 45 (range, 21–137). Cancer of any volume and any grade was detected in 34 of 54 (63%) patients. mp-MRI accuracy at detection of clinically significant cancer using University College London (UCL) definition 2 (any
Sign in with your free account to read, download EPUBs or listen.
Ebook · The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--Can it rule out clinically significant prostate cancer? · Abd-Alazeez, Mohamed, Ahmed, Hashim U., Arya, Manit, Charman, Susan C., Anastasiadis, Eleni, Freeman, Alex, Emberton, Mark, Kirkham, Alex · Internet Archive